Prenatal blood test for fetal DNA
Part of Women’s health & pregnancy clinical trials.
This study looks at a simple blood test that can check the unborn baby's DNA during pregnancy. It may help doctors learn more about the baby's health without any risk to you or the baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are between 6 and 22 weeks pregnant.
- Both you and the baby's father agree to join the study and sign a consent form.
- You do not have HIV, syphilis, or hepatitis B.
- The baby's father is able to give a sample.
- Both parents can understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gene activity in the placenta during early and full-term pregnancy. It may help researchers understand how the placenta works and how it affects both mother and baby.
This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study tests a new blood test that looks for fetal cells in your bloodstream to check your baby's health during pregnancy. The test is non-invasive—just a regular blood draw—and aims to help identify pregnancy risks earlier than traditional methods.
This study looks at fetal DNA in the blood of pregnant women who have cancer, to better understand how the baby and tumor interact. It might help doctors learn more about how cancer affects pregnancy.
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.